Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Copaxone
Pharma
Teva's patent and communications strategies in Turkey face probe
But Teva's foot in both realms is now being highlighted as it faces scrutiny over whether it stymied generics to its innovative drugs in Turkey.
Fraiser Kansteiner
,
Zoey Becker
Aug 26, 2026 8:15am
Teva's Copaxone gets boxed warning for anaphylaxis risk
Jan 23, 2025 7:52am
Teva hit with €463M fine over Copaxone misconduct claims in EU
Oct 31, 2024 10:45am
Teva to pay $450M to settle longstanding kickback allegations
Oct 11, 2024 9:23am
Teva faces fresh Copaxone kickbacks lawsuit
Aug 20, 2024 1:12pm
Viatris, Mapi's long-acting MS drug rebuffed by FDA
Mar 11, 2024 11:11am